Marinomed Biotech AG (MARI.VI)

EUR 12.45

(2.05%)

Operating Income Summary of Marinomed Biotech AG

Marinomed Biotech AG's latest annual operating income in 2023 was -5.12 Million EUR , down -32.3% from previous year.
Marinomed Biotech AG's latest quarterly operating income in 2024 Q1 was -1.87 Million EUR , down -157.47% from previous quarter.
Marinomed Biotech AG reported an annual operating income of -4.91 Million EUR in 2022, down -18.55% from previous year.
Marinomed Biotech AG reported an annual operating income of -4.14 Million EUR in 2021, up 28.74% from previous year.
Marinomed Biotech AG reported a quarterly operating income of -6.5 Million EUR for 2023 FY, down -32.3% from previous quarter.
Marinomed Biotech AG reported a quarterly operating income of -1.39 Million EUR for 2023 Q1, down -28.43% from previous quarter.

Annual Operating Income Chart of Marinomed Biotech AG (2023 - 2015)

Historical Annual Operating Income of Marinomed Biotech AG (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-5.12 Million EUR	-32.3%
2022	-4.91 Million EUR	-18.55%
2021	-4.14 Million EUR	28.74%
2020	-5.81 Million EUR	6.35%
2019	-6.21 Million EUR	-20.81%
2018	-5.14 Million EUR	-213.84%
2017	-1.63 Million EUR	-7.34%
2016	-1.52 Million EUR	-26.42%
2015	-1.2 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-1.87 Million EUR	-157.47%
2023 FY	-6.5 Million EUR	-32.3%
2023 Q1	-1.39 Million EUR	-28.43%
2023 Q2	-1.51 Million EUR	-8.94%
2023 Q3	-1.49 Million EUR	1.44%
2023 Q4	-729.3 Thousand EUR	51.17%
2022 Q1	-1.24 Million EUR	-218.24%
2022 FY	-4.91 Million EUR	-18.55%
2022 Q4	-1.08 Million EUR	17.28%
2022 Q3	-1.3 Million EUR	-2.27%
2022 Q2	-1.28 Million EUR	-3.18%
2021 Q1	-1.74 Million EUR	-14.22%
2021 Q3	-1.54 Million EUR	18.54%
2021 Q4	1.04 Million EUR	167.72%
2021 FY	-4.14 Million EUR	28.74%
2021 Q2	-1.9 Million EUR	-9.23%
2020 Q1	-1.4 Million EUR	-51.95%
2020 Q3	-1.39 Million EUR	6.02%
2020 Q4	-1.52 Million EUR	-9.14%
2020 FY	-5.81 Million EUR	6.35%
2020 Q2	-1.48 Million EUR	-5.72%
2019 Q2	-1.42 Million EUR	45.86%
2019 Q1	-2.63 Million EUR	-28.07%
2019 Q4	-925.66 Thousand EUR	24.63%
2019 FY	-6.21 Million EUR	-20.81%
2019 Q3	-1.22 Million EUR	13.8%
2018 Q1	-1.04 Million EUR	-1450.64%
2018 FY	-5.14 Million EUR	-213.84%
2018 Q4	-2.05 Million EUR	-57.58%
2018 Q3	-1.3 Million EUR	-77.11%
2018 Q2	-736.24 Thousand EUR	29.6%
2017 Q4	77.42 Thousand EUR	0.0%
2017 FY	-1.63 Million EUR	-7.34%
2016 FY	-1.52 Million EUR	-26.42%
2015 FY	-1.2 Million EUR	0.0%

Peer Operating Income Comparison of Marinomed Biotech AG

Name	Operating Income	Operating Income Difference